"Cardiac Myosins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Myosin type II isoforms found in cardiac muscle.
| Descriptor ID |
D024722
|
| MeSH Number(s) |
D05.750.078.730.475.475.124 D08.811.277.040.025.193.750.750.124 D12.776.210.500.600.470.249 D12.776.220.525.475.475.124
|
| Concept/Terms |
Cardiac Myosins- Cardiac Myosins
- Cardiac Myosin
- Myosin, Cardiac
- Myosins, Cardiac
- Cardiac Muscle Myosins
- Muscle Myosins, Cardiac
- Myosins, Cardiac Muscle
|
Below are MeSH descriptors whose meaning is more general than "Cardiac Myosins".
Below are MeSH descriptors whose meaning is more specific than "Cardiac Myosins".
This graph shows the total number of publications written about "Cardiac Myosins" by people in this website by year, and whether "Cardiac Myosins" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 2 | 0 | 2 |
| 1999 | 1 | 0 | 1 |
| 2000 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 1 | 2 | 3 |
| 2009 | 1 | 3 | 4 |
| 2010 | 1 | 2 | 3 |
| 2011 | 3 | 1 | 4 |
| 2012 | 2 | 1 | 3 |
| 2013 | 2 | 2 | 4 |
| 2014 | 1 | 2 | 3 |
| 2015 | 2 | 3 | 5 |
| 2016 | 1 | 3 | 4 |
| 2017 | 3 | 0 | 3 |
| 2018 | 2 | 2 | 4 |
| 2019 | 2 | 2 | 4 |
| 2020 | 4 | 2 | 6 |
| 2021 | 1 | 2 | 3 |
| 2022 | 1 | 0 | 1 |
| 2023 | 0 | 3 | 3 |
| 2024 | 2 | 3 | 5 |
Below are the most recent publications written about "Cardiac Myosins" by people in Profiles.
-
Aficamten is a small-molecule cardiac myosin inhibitor designed to treat hypertrophic cardiomyopathy. Nat Cardiovasc Res. 2024 Aug; 3(8):1003-1016.
-
Autoimmune Myocarditis, Old Dogs and New Tricks. Circ Res. 2024 Jun 07; 134(12):1767-1790.
-
Cardiac myosin inhibitor, CK-586, minimally reduces systolic function and ameliorates obstruction in feline hypertrophic cardiomyopathy. Sci Rep. 2024 05 27; 14(1):12038.
-
Aficamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy. N Engl J Med. 2024 May 30; 390(20):1849-1861.
-
Multiplexed Functional Assessments of MYH7 Variants in Human Cardiomyocytes. Circ Genom Precis Med. 2024 Apr; 17(2):e004377.
-
Shedding Light on the Darkness of MYH7 Cardiomyopathies. JACC Heart Fail. 2024 Jan; 12(1):148-149.
-
Hypertrophic cardiomyopathy in purpose-bred cats with the A31P mutation in cardiac myosin binding protein-C. Sci Rep. 2023 06 26; 13(1):10319.
-
Cardiomyocyte Apoptosis Is Associated with Contractile Dysfunction in Stem Cell Model of MYH7 E848G Hypertrophic Cardiomyopathy. Int J Mol Sci. 2023 Mar 03; 24(5).
-
Insights into the Mechanism of the Cardiac Drug Omecamtiv Mecarbil─A Computational Study. J Phys Chem B. 2022 12 08; 126(48):10069-10082.
-
Molecular mechanisms of cardiac actomyosin transforming from rigor state to post-rigor state. J Chem Phys. 2022 Jan 21; 156(3):035101.